MONOTHERAPY

Clinical trials for MONOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new MONOTHERAPY trials appear

Sign up with your email to follow new studies for MONOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug shows promise for NF1 skin tumors in early trial

Disease control Recruiting now

This study tests a drug called mirdametinib in adults with neurofibromatosis type 1 (NF1) who have skin tumors called cutaneous neurofibromas. The goal is to find a safe dose and see if the drug can shrink these tumors. About 24 people will take the drug daily or on a three-week-…

Matched conditions: MONOTHERAPY

Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC

MONOTHERAPY

Get alerted when new MONOTHERAPY trials appear

New drug shows promise for NF1 skin tumors in early trial